RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+12.88%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.25B
AUM Growth
+$3.25B
(+10%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.75%
Holding
101
New
20
Increased
28
Reduced
23
Closed
18
Top Buys
| 1 |
Cigna
CI
|
$77.1M |
| 2 |
ALLK
Allakos
ALLK
|
$65.7M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
$63.1M |
| 4 |
Fate Therapeutics
FATE
|
$60.3M |
| 5 |
Tandem Diabetes Care
TNDM
|
$45.8M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$63.8M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$60.7M |
| 3 |
Labcorp
LH
|
$51.8M |
| 4 |
Insmed
INSM
|
$48.1M |
| 5 |
Centene
CNC
|
$41.4M |
Sector Composition
| 1 | Healthcare | 93.7% |
| 2 | Financials | 1.28% |
| 3 | Energy | 0.69% |
| 4 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $242M | 7.44% | 15,906,680 -71,900 | -0.4% | -$1.09M |
|
2
Atara Biotherapeutics
ATRA
$84.6M
| $174M | 5.37% | 4,218,717 +92,100 | +2% | +$3.81M |
|
|
3
Fate Therapeutics
FATE
$120M
| $169M | 5.19% | 10,359,666 +3,703,704 | +56% | +$60.3M |
|
4
Regenxbio
RGNX
$451M
| $125M | 3.85% | 1,656,065 +94,890 | +6% | +$7.16M |
|
5
Xencor
XNCR
$580M
| $118M | 3.63% | 3,030,143 -116,900 | -4% | -$4.56M |
|
|
IMGN
6
DELISTED
Immunogen Inc
IMGN
| $117M | 3.59% | 12,309,035 -6,907 | -0.1% | -$65.4K |
|
7
Wave Life Sciences
WVE
$1.53B
| $114M | 3.5% | 2,273,307 +28,800 | +1% | +$1.44M |
|
|
ALDR
8
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $108M | 3.33% | 6,505,766 | – | – |
|
9
Amicus Therapeutics
FOLD
$2.34B
| $102M | 3.13% | 8,402,617 -2,109,115 | -20% | -$25.5M |
|
|
BOLD
10
DELISTED
Audentes Therapeutics, Inc
BOLD
| $88.8M | 2.73% | 2,243,356 +14,700 | +0.7% | +$582K |
|
|
11
Cigna
CI
$80.3B
| $77.1M | 2.37% | +370,200 | New | +$77.1M |
|
12
LivaNova
LIVN
$3.08B
| $74.3M | 2.29% | 599,288 -500 | -0.1% | -$62K |
|
13
argenx
ARGX
$43.6B
| $73.9M | 2.27% | 974,506 +301,206 | +45% | +$22.8M |
|
14
InflaRx
IFRX
$108M
| $69.5M | 2.14% | 2,024,900 -2,800 | -0.1% | -$96.1K |
|
|
ALLK
15
DELISTED
Allakos
ALLK
| $65.7M | 2.02% | +1,459,892 | New | +$65.7M |
|
16
Elevance Health
ELV
$71.8B
| $64.1M | 1.97% | 234,000 +88,000 | +60% | +$24.1M |
|
|
WMGI
17
DELISTED
Wright Medical Group Inc
WMGI
| $63.1M | 1.94% | +2,173,700 | New | +$63.1M |
|
18
AnaptysBio
ANAB
$569M
| $62.9M | 1.93% | 630,250 +111,000 | +21% | +$11.1M |
|
19
uniQure
QURE
$896M
| $59.7M | 1.84% | 1,639,900 +15,500 | +1% | +$564K |
|
|
DCPH
20
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $57.2M | 1.76% | 1,476,580 -500 | -0% | -$19.4K |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $52.2M | 1.61% | 1,778,300 +19,700 | +1% | +$579K |
|
22
ICU Medical
ICUI
$3.15B
| $51.5M | 1.58% | 181,972 -2,200 | -1% | -$622K |
|
|
WCG
23
DELISTED
Wellcare Health Plans, Inc.
WCG
| $50M | 1.54% | 155,909 -199,100 | -56% | -$63.8M |
|
|
24
Tandem Diabetes Care
TNDM
$845M
| $45.8M | 1.41% | +1,069,670 | New | +$45.8M |
|
25
Scholar Rock
SRRK
$3.14B
| $45.7M | 1.4% | 1,773,107 +22,699 | +1% | +$585K |
|